EFPIA Newsletter 07 September 2023

News     06 September 2023 EFPIA attends meeting to discuss opt-out requirements in EHDS An opt-out or opt-in mechanism with regard to the secondary use of electronic health data may lead to health data disparities.... Read more →

Blogs     05 September 2023 How the pharmaceutical industry is contributing to mitigate climate change New industry survey highlights commitments and ambitions of 23 global pharmaceutical companies Read more →         01 August 2023 Lung cancer: meeting patients’ needs through innovation An inclusive definition of unmet medical need is vital to driving better outcomes for patients Read more →

New Film Highlights the Threat of AMR

The AMR Action Fund presents “Race Against Resistance: The Life and Death Struggle to Save Antibiotics,” a gripping film that takes viewers inside the world of patients affected by drug-resistant superbugs and highlights the work of clinicians, scientist, and advocates helping to advance new treatments and avert a global catastrophe.

	Race Against Resistance: The Life And Death Struggle To Save Antibiotics BBC StoryWorks

Events     12 SEP 2023   Unlocking the potential of new oncology treatments Virtual event A cross-stakeholder discussion on improving the understanding, acceptance and use of oncology-relevant endpoints in... Learn more →       26 SEP 2023   Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection... Online Moving towards a new Alzheimer’s disease detection and diagnosis pathway Learn more →

	29 SEP 2023			Are medicines affordable for health systems? Bad Hofgastein, Austria The myths, the facts, and the way forward Learn more →

	17 OCT 2023			EFGCP Better Medicines for Children Conference 2023 Amsterdam Global Paediatric Drug Development: the value of multi-stakeholders’ collaboration Learn more →

Delivering treatments to patients: The medicines manufacturing journey Discover the intricate journey from molecule to medicine in our latest leaflet, "Delivering treatments to patients: The medicines manufacturing journey". Explore the world of pharmaceutical manufacturing and learn about EFPIA's commitment, from high quality to shortages prevention. Learn more and join us in spreading awareness about this crucial process.

What we are reading America’s plan to cut drug prices comes with unpleasant side-effects 29 August 2023  (The Economist) Read more → Economic burden of cardiovascular diseases in the European Union: a population-based cost study... 26 August 2023  (European Heart Journal) Read more → PFAS uncertainty: assessing risks and impacts on the pharmaceutical industry 18 August 2023  (PharmaLive) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe